{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:42:00Z","timestamp":1789180920975,"version":"build-2803163510"},"reference-count":114,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pancreatic cancer, as the fourth leading cause of cancer-related deaths, carries a poor prognosis with a median survival of 6 months and a dismal 5-year survival rate of 3% to 5%. These statistics highlight an urgent need for novel chemopreventive and therapeutic strategies for this malignancy. Metformin and aspirin have been explored as two emerging cancer chemoprevention agents for different types of cancers, including pancreatic cancer. Here, we review the effects of both metformin and aspirin on pancreatic tumorigenesis and their potential actions in pancreatic cancer. Special attention is paid to their effects on the important signaling pathways of pancreatic cancer development as well as possible mechanisms for synergy between these two agents. For metformin, the most important mechanism may involve the inhibition of mTOR signaling via AMP-activated protein kinase (AMPK)-dependent and -independent pathways. For aspirin, the major mechanism is the anti-inflammatory action through the inhibition of COX-1\/COX-2 and modulation of the NF\u03baB or STAT3 pathway. In addition, aspirin may activate AMPK, and both agents may affect Notch, Wnt\/\u03b2-catenin, and other signaling pathways. The combination of metformin and aspirin will provide additive and possibly synergistic effects for the prevention and treatment of pancreatic cancer. Cancer Prev Res; 7(4); 388\u201397. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-13-0337","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T02:39:27Z","timestamp":1392172767000},"page":"388-397","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Repurposing of Metformin and Aspirin by Targeting AMPK-mTOR and Inflammation for Pancreatic Cancer Prevention and Treatment"],"prefix":"10.1158","volume":"7","author":[{"given":"Wen","family":"Yue","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick; 2Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy; and 3Department of Epidemiology, School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung S.","family":"Yang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick; 2Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy; and 3Department of Epidemiology, School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey"},{"name":"Authors' Affiliations:\u20081Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick; 2Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy; and 3Department of Epidemiology, School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"DiPaola","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick; 2Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy; and 3Department of Epidemiology, School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Lin","family":"Tan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick; 2Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy; and 3Department of Epidemiology, School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey"},{"name":"Authors' Affiliations:\u20081Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick; 2Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy; and 3Department of Epidemiology, School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"2022060816242369300_bib1","article-title":"Cancer Facts & Figures 2014","author":"Society AC","year":"2014"},{"key":"2022060816242369300_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrgastro.2010.61","article-title":"Chemoprevention strategies for pancreatic cancer","volume":"7","author":"Stan","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2022060816242369300_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOG.0b013e3283567f69","article-title":"Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu","volume":"28","author":"Kumar-Sinha","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"2022060816242369300_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/IJGC:33:1:27","article-title":"Chemoprevention for pancreatic cancer","volume":"33","author":"Wolff","year":"2003","journal-title":"Int J Gastrointest Cancer"},{"key":"2022060816242369300_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1055-3207(18)30285-0","article-title":"Epidemiology of and risk factors for pancreatic cancer","volume":"7","author":"Gold","year":"1998","journal-title":"Surg Oncol Clin N Am"},{"key":"2022060816242369300_bib6","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/jnci\/86.20.1510","article-title":"Cigarette smoking and pancreas cancer: a case-control study based on direct interviews","volume":"86","author":"Silverman","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"2022060816242369300_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mc.20771","article-title":"Diabetes and pancreatic cancer","volume":"51","author":"Li","year":"2012","journal-title":"Mol Carcinog"},{"key":"2022060816242369300_bib8","doi-asserted-by":"crossref","first-page":"G315","DOI":"10.1152\/ajpgi.00115.2004","article-title":"Inflammation and cancer v. chronic pancreatitis and pancreatic cancer","volume":"287","author":"Whitcomb","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022060816242369300_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0960-7404(02)00015-4","article-title":"Inflammation and the development of pancreatic cancer","volume":"10","author":"Farrow","year":"2002","journal-title":"Surg Oncol"},{"key":"2022060816242369300_bib10","first-page":"128","article-title":"Tumor microenvironment and progression of pancreatic cancer","volume":"32","author":"Erkan","year":"2010","journal-title":"Exp Oncol"},{"key":"2022060816242369300_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1172\/JCI40045","article-title":"Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice","volume":"120","author":"Morris","year":"2010","journal-title":"J Clin Invest"},{"key":"2022060816242369300_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1053\/j.gastro.2013.02.007","article-title":"Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer","volume":"144","author":"Gukovsky","year":"2013","journal-title":"Gastroenterology"},{"key":"2022060816242369300_bib13","first-page":"283","article-title":"Discovering the route from inflammation to pancreatic cancer","volume":"58","author":"Momi","year":"2012","journal-title":"Minerva Gastroenterol Dietol"},{"key":"2022060816242369300_bib14","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2013.01.071","article-title":"Roles for KRAS in pancreatic tumor development and progression","volume":"144","author":"di Magliano","year":"2013","journal-title":"Gastroenterology"},{"key":"2022060816242369300_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci"},{"key":"2022060816242369300_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"2022060816242369300_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2407-11-20","article-title":"Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer"},{"key":"2022060816242369300_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ajg.2011.483","article-title":"Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis","volume":"107","author":"Bodmer","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2022060816242369300_bib19","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-11-2994","article-title":"Metformin use is associated with better survival of diabetic patients with pancreatic cancer","volume":"18","author":"Sadeghi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2022060816242369300_bib20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ajg.2013.7","article-title":"Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"2022060816242369300_bib21","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1158\/0008-5472.CAN-09-0418","article-title":"Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth","volume":"69","author":"Kisfalvi","year":"2009","journal-title":"Cancer Res"},{"key":"2022060816242369300_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbrc.2012.11.010","article-title":"Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK","volume":"430","author":"Sinnett-Smith","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"2022060816242369300_bib23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1053\/gast.2001.23258","article-title":"Prevention of pancreatic cancer induction in hamsters by metformin","volume":"120","author":"Schneider","year":"2001","journal-title":"Gastroenterology"},{"key":"2022060816242369300_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2022060816242369300_bib25","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1940-6207.CAPR-11-0146","article-title":"Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study","volume":"4","author":"Tan","year":"2011","journal-title":"Cancer Prev Res"},{"key":"2022060816242369300_bib26","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1158\/1055-9965.EPI-06-0574","article-title":"Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis","volume":"15","author":"Larsson","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816242369300_bib27","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1365-2036.2007.03495.x","article-title":"Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories","volume":"26","author":"Capurso","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2022060816242369300_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"2022060816242369300_bib29","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/cncr.21075","article-title":"Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin","volume":"103","author":"Sclabas","year":"2005","journal-title":"Cancer"},{"key":"2022060816242369300_bib30","first-page":"185","article-title":"NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review)","volume":"29","author":"Zhang","year":"2006","journal-title":"Int J Oncol"},{"key":"2022060816242369300_bib31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/gut.2009.188961","article-title":"The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer","volume":"59","author":"Fendrich","year":"2010","journal-title":"Gut"},{"key":"2022060816242369300_bib32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1593\/neo.121026","article-title":"Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre\/+)-LSL-Kras(G12D\/+) mice","volume":"14","author":"Rao","year":"2012","journal-title":"Neoplasia"},{"key":"2022060816242369300_bib33","doi-asserted-by":"crossref","first-page":"e76518","DOI":"10.1371\/journal.pone.0076518","article-title":"Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells","volume":"8","author":"Lonardo","year":"2013","journal-title":"PLoS ONE"},{"key":"2022060816242369300_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-2952(88)90729-0","article-title":"2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism","volume":"37","author":"Grootveld","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"2022060816242369300_bib35","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1038\/srep03230","article-title":"mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions","volume":"3","author":"Matsubara","year":"2013","journal-title":"Sci Rep"},{"key":"2022060816242369300_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2005.03.166","article-title":"The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation","volume":"331","author":"Asano","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2022060816242369300_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2407-8-43","article-title":"Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis","volume":"8","author":"Pham","year":"2008","journal-title":"BMC Cancer"},{"key":"2022060816242369300_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.febslet.2007.11.018","article-title":"Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease","volume":"582","author":"Hardie","year":"2008","journal-title":"FEBS Lett"},{"key":"2022060816242369300_bib39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"O'Neill","year":"2013","journal-title":"Nature"},{"key":"2022060816242369300_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1741-7015-9-33","article-title":"Understanding the benefit of metformin use in cancer treatment","volume":"9","author":"Dowling","year":"2011","journal-title":"BMC Med"},{"key":"2022060816242369300_bib41","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1215327","article-title":"The ancient drug salicylate directly activates AMP-activated protein kinase","volume":"336","author":"Hawley","year":"2012","journal-title":"Science"},{"key":"2022060816242369300_bib42","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"2022060816242369300_bib43","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz","year":"2010","journal-title":"J Clin Invest"},{"key":"2022060816242369300_bib44","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1172\/JCI43661","article-title":"An energetic tale of AMPK-independent effects of metformin","volume":"120","author":"Miller","year":"2010","journal-title":"J Clin Invest"},{"key":"2022060816242369300_bib45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"2022060816242369300_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022060816242369300_bib47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3816\/CBC.2008.n.060","article-title":"Insulin-lowering effects of metformin in women with early breast cancer","volume":"8","author":"Goodwin","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"2022060816242369300_bib48","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/onc.2010.483","article-title":"Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo","volume":"30","author":"Algire","year":"2011","journal-title":"Oncogene"},{"key":"2022060816242369300_bib49","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"2022060816242369300_bib50","doi-asserted-by":"crossref","first-page":"24944","DOI":"10.1074\/jbc.M300423200","article-title":"Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases","volume":"278","author":"Gao","year":"2003","journal-title":"J Biol Chem"},{"key":"2022060816242369300_bib51","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1188\/12.ONF.440-443","article-title":"Management of diabetes and pancreatic cancer","volume":"39","author":"Flaherty","year":"2012","journal-title":"Oncol Nurs Forum"},{"key":"2022060816242369300_bib52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","article-title":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner","volume":"11","author":"Kalender","year":"2010","journal-title":"Cell Metab"},{"key":"2022060816242369300_bib53","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","article-title":"Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1","volume":"71","author":"Ben Sahra","year":"2011","journal-title":"Cancer Res"},{"key":"2022060816242369300_bib54","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/embor.2009.243","article-title":"IKK\/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis","volume":"10","author":"Bollrath","year":"2009","journal-title":"EMBO Rep"},{"key":"2022060816242369300_bib55","first-page":"119","article-title":"The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells","volume":"5","author":"Wang","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2022060816242369300_bib56","doi-asserted-by":"crossref","first-page":"16452","DOI":"10.1074\/jbc.M309789200","article-title":"Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells","volume":"279","author":"Niu","year":"2004","journal-title":"J Biol Chem"},{"key":"2022060816242369300_bib57","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.onc.1206323","article-title":"Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis","volume":"22","author":"Fujioka","year":"2003","journal-title":"Oncogene"},{"key":"2022060816242369300_bib58","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0016-5085(03)01064-3","article-title":"Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer","volume":"125","author":"Scholz","year":"2003","journal-title":"Gastroenterology"},{"key":"2022060816242369300_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3835(03)00482-8","article-title":"Blockade of constitutively activated Janus kinase\/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer","volume":"201","author":"Toyonaga","year":"2003","journal-title":"Cancer Lett"},{"key":"2022060816242369300_bib60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccr.2011.03.002","article-title":"Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression","volume":"19","author":"Fukuda","year":"2011","journal-title":"Cancer Cell"},{"key":"2022060816242369300_bib61","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","article-title":"STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis","volume":"71","author":"Corcoran","year":"2011","journal-title":"Cancer Res"},{"key":"2022060816242369300_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2009.02.015","article-title":"Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors","volume":"15","author":"Lee","year":"2009","journal-title":"Cancer Cell"},{"key":"2022060816242369300_bib63","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2022060816242369300_bib64","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022060816242369300_bib65","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1016\/S0021-9258(19)38515-1","article-title":"Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells","volume":"265","author":"Maier","year":"1990","journal-title":"J Biol Chem"},{"key":"2022060816242369300_bib66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N","article-title":"Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors","volume":"91","author":"Kokawa","year":"2001","journal-title":"Cancer"},{"key":"2022060816242369300_bib67","first-page":"987","article-title":"Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer","volume":"59","author":"Tucker","year":"1999","journal-title":"Cancer Res"},{"key":"2022060816242369300_bib68","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"2022060816242369300_bib69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"2022060816242369300_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00384-010-1060-0","article-title":"Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6-STAT3 signaling pathway","volume":"26","author":"Tian","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"2022060816242369300_bib71","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbrc.2009.07.022","article-title":"Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells","volume":"387","author":"Kim","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2022060816242369300_bib72","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000221429.94591.72","article-title":"Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells","volume":"47","author":"Hattori","year":"2006","journal-title":"Hypertension"},{"key":"2022060816242369300_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2008.04.010","article-title":"Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation","volume":"134","author":"Huang","year":"2009","journal-title":"Int J Cardiol"},{"key":"2022060816242369300_bib74","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1476-5381.2010.01101.x","article-title":"Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation","volume":"162","author":"Kim","year":"2011","journal-title":"Br J Pharmacol"},{"key":"2022060816242369300_bib75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4161\/cc.11.2.18813","article-title":"Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers","volume":"11","author":"Deng","year":"2012","journal-title":"Cell Cycle"},{"key":"2022060816242369300_bib76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1165\/rcmb.2012-0244OC","article-title":"Metformin enhances cisplatin cytotoxicity by suppressing Stat3 activity independently of the LKB1-AMPK pathway","volume":"49","author":"Lin","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022060816242369300_bib77","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","article-title":"AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan","volume":"89","author":"Salminen","year":"2011","journal-title":"J Mol Med"},{"key":"2022060816242369300_bib78","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.4161\/cc.22388","article-title":"Epigenetic silencing of Notch signaling in gastrointestinal cancers","volume":"11","author":"Piazzi","year":"2012","journal-title":"Cell Cycle"},{"key":"2022060816242369300_bib79","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.molmed.2013.03.003","article-title":"Notch signaling in pancreatic cancer: oncogene or tumor suppressor?","volume":"19","author":"Avila","year":"2013","journal-title":"Trends Mol Med"},{"key":"2022060816242369300_bib80","doi-asserted-by":"crossref","first-page":"18907","DOI":"10.1073\/pnas.0810111105","article-title":"Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia","volume":"105","author":"De La","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816242369300_bib81","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2009.01.008","article-title":"Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma","volume":"136","author":"Plentz","year":"2009","journal-title":"Gastroenterology"},{"key":"2022060816242369300_bib82","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1158\/0008-5472.CAN-09-4645","article-title":"Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma","volume":"70","author":"Hanlon","year":"2010","journal-title":"Cancer Res"},{"key":"2022060816242369300_bib83","doi-asserted-by":"crossref","first-page":"13438","DOI":"10.1073\/pnas.1002423107","article-title":"Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma","volume":"107","author":"Mazur","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816242369300_bib84","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1172\/JCI45797","article-title":"Crosstalk between the canonical NF-kappaB and Notch signaling pathways inhibits Ppargamma expression and promotes pancreatic cancer progression in mice","volume":"121","author":"Maniati","year":"2011","journal-title":"J Clin Invest"},{"key":"2022060816242369300_bib85","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/1940-6207.CAPR-11-0299","article-title":"Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells","volume":"5","author":"Bao","year":"2012","journal-title":"Cancer Prev Res"},{"key":"2022060816242369300_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2022060816242369300_bib87","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","article-title":"Dysregulation of Wnt\/beta-catenin signaling in gastrointestinal cancers","volume":"142","author":"White","year":"2012","journal-title":"Gastroenterology"},{"key":"2022060816242369300_bib88","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc2899","article-title":"KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma","volume":"10","author":"Morris","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2022060816242369300_bib89","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1371\/journal.pone.0001155","article-title":"Common activation of canonical Wnt signaling in pancreatic adenocarcinoma","volume":"2","author":"Pasca di Magliano","year":"2007","journal-title":"PLoS ONE"},{"key":"2022060816242369300_bib90","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2009.01.018","article-title":"Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization","volume":"15","author":"Wang","year":"2009","journal-title":"Cancer Cell"},{"key":"2022060816242369300_bib91","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1158\/0008-5472.CAN-12-4384","article-title":"Canonical Wnt signaling is required for pancreatic carcinogenesis","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res"},{"key":"2022060816242369300_bib92","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1038\/sj.onc.1209658","article-title":"Effect of aspirin on the Wnt\/beta-catenin pathway is mediated via protein phosphatase 2A","volume":"25","author":"Bos","year":"2006","journal-title":"Oncogene"},{"key":"2022060816242369300_bib93","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2184.2009.00639.x","article-title":"Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt\/beta-catenin pathway","volume":"42","author":"Deng","year":"2009","journal-title":"Cell Prolif"},{"key":"2022060816242369300_bib94","doi-asserted-by":"crossref","first-page":"e53597","DOI":"10.1371\/journal.pone.0053597","article-title":"AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt\/beta-catenin signaling activity","volume":"8","author":"Kwan","year":"2013","journal-title":"PLoS ONE"},{"key":"2022060816242369300_bib95","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1940-6207.CAPR-12-0053","article-title":"Metformin-mediated Bambi expression in hepatic stellate cells induces prosurvival Wnt\/beta-catenin signaling","volume":"5","author":"Subramaniam","year":"2012","journal-title":"Cancer Prev Res"},{"key":"2022060816242369300_bib96","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1073\/pnas.1221055110","article-title":"Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth","volume":"110","author":"Hirsch","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816242369300_bib97","doi-asserted-by":"crossref","first-page":"e63969","DOI":"10.1371\/journal.pone.0063969","article-title":"Low concentrations of metformin selectively inhibit CD133(+) cell proliferation in pancreatic cancer and have anticancer action","volume":"8","author":"Gou","year":"2013","journal-title":"PLoS ONE"},{"key":"2022060816242369300_bib98","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5966\/sctm.2012-0058","article-title":"Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK","volume":"1","author":"Sato","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"2022060816242369300_bib99","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"key":"2022060816242369300_bib100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/1940-6207.CAPR-13-0312","article-title":"Combination of chemoprevention agents in nanoparticles for cancer prevention","volume":"6","author":"Yang","year":"2013","journal-title":"Cancer Prev Res"},{"key":"2022060816242369300_bib101","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000094560","article-title":"Chemoprevention of pancreatic cancer: a review of the molecular pathways involved, and evidence for the potential for chemoprevention","volume":"6","author":"Doucas","year":"2006","journal-title":"Pancreatology"},{"key":"2022060816242369300_bib102","first-page":"4379","article-title":"Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3","volume":"26","author":"Su","year":"2006","journal-title":"Anticancer Res"},{"key":"2022060816242369300_bib103","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann Intern Med"},{"key":"2022060816242369300_bib104","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res"},{"key":"2022060816242369300_bib105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1158\/1940-6207.CAPR-11-0391","article-title":"Aspirin in the chemoprevention of colorectal neoplasia: an overview","volume":"5","author":"Chan","year":"2012","journal-title":"Cancer Prev Res"},{"key":"2022060816242369300_bib106","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1080\/03639040802130061","article-title":"Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery","volume":"34","author":"Muchow","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"key":"2022060816242369300_bib107","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2217\/nnm.12.128","article-title":"Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives","volume":"7","author":"Mattheolabakis","year":"2012","journal-title":"Nanomedicine"},{"key":"2022060816242369300_bib108","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2012.06.002","article-title":"Improvement of drug safety by the use of lipid-based nanocarriers","volume":"163","author":"Lim","year":"2012","journal-title":"J Control Release"},{"key":"2022060816242369300_bib109","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.colsurfb.2007.03.002","article-title":"Studies on oral absorption of stearic acid SLN by a novel fluorometric method","volume":"58","author":"Yuan","year":"2007","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2022060816242369300_bib110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/17425247.2012.673278","article-title":"Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery","volume":"9","author":"Battaglia","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"2022060816242369300_bib111","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/1940-6207.CAPR-13-0172","article-title":"A novel combinatorial naotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions","volume":"6","author":"Grandhi","year":"2013","journal-title":"Cancer Prev Res"},{"key":"2022060816242369300_bib112","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.ju.0000142058.99614.ff","article-title":"The role of inflammation in the pathogenesis of prostate cancer","volume":"172","author":"Nelson","year":"2004","journal-title":"J Urol"},{"key":"2022060816242369300_bib113","doi-asserted-by":"crossref","first-page":"461S","DOI":"10.1093\/ajcn\/83.2.461S","article-title":"Obesity and the role of adipose tissue in inflammation and metabolism","volume":"83","author":"Greenberg","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"2022060816242369300_bib114","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/4\/388\/2253407\/388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/4\/388\/2253407\/388.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T18:31:29Z","timestamp":1654713089000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/7\/4\/388\/50316\/Repurposing-of-Metformin-and-Aspirin-by-Targeting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":114,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,1]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-13-0337","relation":{},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}